Reassessment of the role of induction chemotherapy for head and neck cancer (Q36524702)

14 August 2017

1 reference

title

Reassessment of the role of induction chemotherapy for head and neck cancer (English)

1 reference

14 August 2017

1 reference

Michael K Gibson

1

1 reference

PubMed ID

16814208

14 August 2017

Arlene A Forastiere

series ordinal

2

1 reference

14 August 2017

1 July 2006

1 reference

Lancet Oncology Commission

14 August 2017

1 reference

14 August 2017

7

1 reference

14 August 2017

7

1 reference

14 August 2017

565-574

1 reference

14 August 2017

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

The changing demographics of head and neck squamous cell carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

1 reference

7 January 2021

Head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

The expanding role of systemic therapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Is there a new role for induction chemotherapy in the treatment of head and neck cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Is there still a role for neoadjuvant chemotherapy in head and neck cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

State-of-the-art management of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Impact of tumor hypoxia and anemia on radiation therapy outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Hypoxia--a key regulatory factor in tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Influence of the hypoxic subvolume on the survival of patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Tumor volume and tumor hypoxia in head and neck cancers. The amount of the hypoxic volume is important.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Development of distant metastasis after treatment of advanced-stage head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Does histologic grade have a role in the management of head and neck cancers?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970757-4

7 January 2021

10.1016/S1470-2045(06)70757-4

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16814208